List of Tables
Table 1. Global Synthetic Peptide Vaccine Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Synthetic Peptide Vaccine Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Synthetic Peptide Vaccine Market Competitive Situation by Manufacturers in 2025
Table 4. Global Synthetic Peptide Vaccine Sales (M ml) of Key Manufacturers (2021–2026)
Table 5. Global Synthetic Peptide Vaccine Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Synthetic Peptide Vaccine Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Synthetic Peptide Vaccine Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Synthetic Peptide Vaccine Average Price (US$/L) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Synthetic Peptide Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Synthetic Peptide Vaccine, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Synthetic Peptide Vaccine, Product Types and Applications
Table 12. Global Key Manufacturers of Synthetic Peptide Vaccine, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Synthetic Peptide Vaccine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Synthetic Peptide Vaccine Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Synthetic Peptide Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Synthetic Peptide Vaccine Sales by Region (M ml), 2021–2026
Table 18. Global Synthetic Peptide Vaccine Sales Market Share by Region (2021–2026)
Table 19. Global Synthetic Peptide Vaccine Sales by Region (M ml), 2027–2032
Table 20. Global Synthetic Peptide Vaccine Sales Market Share by Region (2027–2032)
Table 21. Global Synthetic Peptide Vaccine Revenue by Region (US$ Million), 2021–2026
Table 22. Global Synthetic Peptide Vaccine Revenue Market Share by Region (2021–2026)
Table 23. Global Synthetic Peptide Vaccine Revenue by Region (US$ Million), 2027–2032
Table 24. Global Synthetic Peptide Vaccine Revenue Market Share by Region (2027–2032)
Table 25. North America Synthetic Peptide Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Synthetic Peptide Vaccine Sales by Country (M ml), 2021–2026
Table 27. North America Synthetic Peptide Vaccine Sales by Country (M ml), 2027–2032
Table 28. North America Synthetic Peptide Vaccine Revenue by Country (US$ Million), 2021–2026
Table 29. North America Synthetic Peptide Vaccine Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Synthetic Peptide Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Synthetic Peptide Vaccine Sales by Country (M ml), 2021–2026
Table 32. Europe Synthetic Peptide Vaccine Sales by Country (M ml), 2027–2032
Table 33. Europe Synthetic Peptide Vaccine Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Synthetic Peptide Vaccine Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Synthetic Peptide Vaccine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Synthetic Peptide Vaccine Sales by Region (M ml), 2021–2026
Table 37. Asia Pacific Synthetic Peptide Vaccine Sales by Region (M ml), 2027–2032
Table 38. Asia Pacific Synthetic Peptide Vaccine Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Synthetic Peptide Vaccine Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Synthetic Peptide Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Synthetic Peptide Vaccine Sales by Country (M ml), 2021–2026
Table 42. Latin America Synthetic Peptide Vaccine Sales by Country (M ml), 2027–2032
Table 43. Latin America Synthetic Peptide Vaccine Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Synthetic Peptide Vaccine Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Synthetic Peptide Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Synthetic Peptide Vaccine Sales by Country (M ml), 2021–2026
Table 47. Middle East and Africa Synthetic Peptide Vaccine Sales by Country (M ml), 2027–2032
Table 48. Middle East and Africa Synthetic Peptide Vaccine Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Synthetic Peptide Vaccine Revenue by Country (US$ Million), 2027–2032
Table 50. Global Synthetic Peptide Vaccine Sales (M ml) by Type (2021–2026)
Table 51. Global Synthetic Peptide Vaccine Sales (M ml) by Type (2027–2032)
Table 52. Global Synthetic Peptide Vaccine Sales Market Share by Type (2021–2026)
Table 53. Global Synthetic Peptide Vaccine Sales Market Share by Type (2027–2032)
Table 54. Global Synthetic Peptide Vaccine Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Synthetic Peptide Vaccine Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Synthetic Peptide Vaccine Revenue Market Share by Type (2021–2026)
Table 57. Global Synthetic Peptide Vaccine Revenue Market Share by Type (2027–2032)
Table 58. Global Synthetic Peptide Vaccine Price (US$/L) by Type (2021–2026)
Table 59. Global Synthetic Peptide Vaccine Price (US$/L) by Type (2027–2032)
Table 60. Global Synthetic Peptide Vaccine Sales (M ml) by Application (2021–2026)
Table 61. Global Synthetic Peptide Vaccine Sales (M ml) by Application (2027–2032)
Table 62. Global Synthetic Peptide Vaccine Sales Market Share by Application (2021–2026)
Table 63. Global Synthetic Peptide Vaccine Sales Market Share by Application (2027–2032)
Table 64. Global Synthetic Peptide Vaccine Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Synthetic Peptide Vaccine Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Synthetic Peptide Vaccine Revenue Market Share by Application (2021–2026)
Table 67. Global Synthetic Peptide Vaccine Revenue Market Share by Application (2027–2032)
Table 68. Global Synthetic Peptide Vaccine Price (US$/L) by Application (2021–2026)
Table 69. Global Synthetic Peptide Vaccine Price (US$/L) by Application (2027–2032)
Table 70. United Biomedical Company Information
Table 71. United Biomedical Description and Business Overview
Table 72. United Biomedical Synthetic Peptide Vaccine Sales (M ml), Revenue (US$ Million), Price (US$/L), and Gross Margin (2021–2026)
Table 73. United Biomedical Synthetic Peptide Vaccine Product
Table 74. United Biomedical Recent Developments/Updates
Table 75. CAHIC Company Information
Table 76. CAHIC Description and Business Overview
Table 77. CAHIC Synthetic Peptide Vaccine Sales (M ml), Revenue (US$ Million), Price (US$/L), and Gross Margin (2021–2026)
Table 78. CAHIC Synthetic Peptide Vaccine Product
Table 79. CAHIC Recent Developments/Updates
Table 80. Xinjiang Tecon Company Information
Table 81. Xinjiang Tecon Description and Business Overview
Table 82. Xinjiang Tecon Synthetic Peptide Vaccine Sales (M ml), Revenue (US$ Million), Price (US$/L), and Gross Margin (2021–2026)
Table 83. Xinjiang Tecon Synthetic Peptide Vaccine Product
Table 84. Xinjiang Tecon Recent Developments/Updates
Table 85. ISA Pharmaceuticals Company Information
Table 86. ISA Pharmaceuticals Description and Business Overview
Table 87. ISA Pharmaceuticals Synthetic Peptide Vaccine Sales (M ml), Revenue (US$ Million), Price (US$/L), and Gross Margin (2021–2026)
Table 88. ISA Pharmaceuticals Synthetic Peptide Vaccine Product
Table 89. ISA Pharmaceuticals Recent Developments/Updates
Table 90. Lytix Biopharma Company Information
Table 91. Lytix Biopharma Description and Business Overview
Table 92. Lytix Biopharma Synthetic Peptide Vaccine Sales (M ml), Revenue (US$ Million), Price (US$/L), and Gross Margin (2021–2026)
Table 93. Lytix Biopharma Synthetic Peptide Vaccine Product
Table 94. Lytix Biopharma Recent Developments/Updates
Table 95. Merck Company Information
Table 96. Merck Description and Business Overview
Table 97. Merck Synthetic Peptide Vaccine Sales (M ml), Revenue (US$ Million), Price (US$/L), and Gross Margin (2021–2026)
Table 98. Merck Synthetic Peptide Vaccine Product
Table 99. Merck Recent Developments/Updates
Table 100. OncoTherapy Science Company Information
Table 101. OncoTherapy Science Description and Business Overview
Table 102. OncoTherapy Science Synthetic Peptide Vaccine Sales (M ml), Revenue (US$ Million), Price (US$/L), and Gross Margin (2021–2026)
Table 103. OncoTherapy Science Synthetic Peptide Vaccine Product
Table 104. OncoTherapy Science Recent Developments/Updates
Table 105. Circio Company Information
Table 106. Circio Description and Business Overview
Table 107. Circio Synthetic Peptide Vaccine Sales (M ml), Revenue (US$ Million), Price (US$/L), and Gross Margin (2021–2026)
Table 108. Circio Synthetic Peptide Vaccine Product
Table 109. Circio Recent Developments/Updates
Table 110. Stemline Therapeutics Company Information
Table 111. Stemline Therapeutics Description and Business Overview
Table 112. Stemline Therapeutics Synthetic Peptide Vaccine Sales (M ml), Revenue (US$ Million), Price (US$/L), and Gross Margin (2021–2026)
Table 113. Stemline Therapeutics Synthetic Peptide Vaccine Product
Table 114. Stemline Therapeutics Recent Developments/Updates
Table 115. Treos Bio Company Information
Table 116. Treos Bio Description and Business Overview
Table 117. Treos Bio Synthetic Peptide Vaccine Sales (M ml), Revenue (US$ Million), Price (US$/L), and Gross Margin (2021–2026)
Table 118. Treos Bio Synthetic Peptide Vaccine Product
Table 119. Treos Bio Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Synthetic Peptide Vaccine Distributors List
Table 123. Synthetic Peptide Vaccine Customers List
Table 124. Synthetic Peptide Vaccine Market Trends
Table 125. Synthetic Peptide Vaccine Market Drivers
Table 126. Synthetic Peptide Vaccine Market Challenges
Table 127. Synthetic Peptide Vaccine Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Synthetic Peptide Vaccine
Figure 2. Global Synthetic Peptide Vaccine Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Synthetic Peptide Vaccine Market Share by Type: 2025 & 2032
Figure 4. FMD Type O Product Picture
Figure 5. FMD Type O+A Product Picture
Figure 6. Others Product Picture
Figure 7. Global Synthetic Peptide Vaccine Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Synthetic Peptide Vaccine Market Share by Application: 2025 & 2032
Figure 9. Government Procurement
Figure 10. Direct Sales
Figure 11. Global Synthetic Peptide Vaccine Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Synthetic Peptide Vaccine Market Size (US$ Million), 2021–2032
Figure 13. Global Synthetic Peptide Vaccine Sales (M ml), 2021–2032
Figure 14. Global Synthetic Peptide Vaccine Average Price (US$/L), 2021–2032
Figure 15. Synthetic Peptide Vaccine Report Years Considered
Figure 16. Synthetic Peptide Vaccine Sales Share by Manufacturers in 2025
Figure 17. Global Synthetic Peptide Vaccine Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Synthetic Peptide Vaccine Players: Market Share by Revenue in Synthetic Peptide Vaccine in 2025
Figure 19. Synthetic Peptide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Synthetic Peptide Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Synthetic Peptide Vaccine Sales Market Share by Country (2021–2032)
Figure 22. North America Synthetic Peptide Vaccine Revenue Market Share by Country (2021–2032)
Figure 23. United States Synthetic Peptide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Synthetic Peptide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Synthetic Peptide Vaccine Sales Market Share by Country (2021–2032)
Figure 26. Europe Synthetic Peptide Vaccine Revenue Market Share by Country (2021–2032)
Figure 27. Germany Synthetic Peptide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Synthetic Peptide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Synthetic Peptide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Synthetic Peptide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Synthetic Peptide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Synthetic Peptide Vaccine Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Synthetic Peptide Vaccine Revenue Market Share by Region (2021–2032)
Figure 34. China Synthetic Peptide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Synthetic Peptide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Synthetic Peptide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Synthetic Peptide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Synthetic Peptide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Synthetic Peptide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Indonesia Synthetic Peptide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Thailand Synthetic Peptide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Malaysia Synthetic Peptide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Synthetic Peptide Vaccine Sales Market Share by Country (2021–2032)
Figure 44. Latin America Synthetic Peptide Vaccine Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Synthetic Peptide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Synthetic Peptide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Synthetic Peptide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Synthetic Peptide Vaccine Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Synthetic Peptide Vaccine Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Synthetic Peptide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Synthetic Peptide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Synthetic Peptide Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Synthetic Peptide Vaccine by Type (2021–2032)
Figure 54. Global Revenue Market Share of Synthetic Peptide Vaccine by Type (2021–2032)
Figure 55. Global Synthetic Peptide Vaccine Price (US$/L) by Type (2021–2032)
Figure 56. Global Sales Market Share of Synthetic Peptide Vaccine by Application (2021–2032)
Figure 57. Global Revenue Market Share of Synthetic Peptide Vaccine by Application (2021–2032)
Figure 58. Global Synthetic Peptide Vaccine Price (US$/L) by Application (2021–2032)
Figure 59. Synthetic Peptide Vaccine Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
